Closed xz-keg closed 1 week ago
107,Chile
ping @corneliusroemer S:A1174X (V,T) seems convergent right now for unknown reason seem to confer some additional advantage. Maybe worth designating this and see if the other will follow the path or fade away as it happens frequently
191 now with a striking 25% in Brazil in September close to 30% in Rio after August 1, Ping @corneliusroemer On S:A1174X i have found some interesting references: In this study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290734/ authors (Yamamoto et al) grew different variants along wioth plasma from patients with different immunity, S:A1174T has been acquired quite quickly and showed strong resistnace to vaccinated people serum.
cc @ryhisner @aviczhl2 @thomasppeacock
49/184=27% prevalence in Brazilian Sep seqs.
201 and apparently (and unexpectedly) competitive vs Kp.3.1.1 baseline, maybe due to high prevalence in Brazil
232 seqs now.
ping @corneliusroemer this needs a designation
250, Mexico,Germany
This is consistently slighty faster than Kp.3.1.1 baseline that for a KP.2.3 is quite a thing.
This is consistently slighty faster than Kp.3.1.1 baseline that for a KP.2.3 is quite a thing.
I have a feeling that KP.2.3 is more advanterous in some regions than KP.3.1.1. Recent batches from China also show a quite unexpected rise of KP.2.2 and KP.2.3 while KP.3.1.1 decays.
267, Ukraine, Argentina, Luxembourg
Around 20% in Brazil after September 15 sampled in 3 states and in a passenger from Brazil via GBW
296 seqs now, also in Austria
Designated KP.2.3.12
From https://github.com/sars-cov-2-variants/lineage-proposals/issues/1843
KP.2.3(with 31del)+C28714T+C11518T+C25083T(S:A1174V)
GISAID query: C28714T, C11518T, C25083T No. of seqs: 104(Belgium 1 Brazil 18 Canada 3 Denmark 1 UK 8 France 8 Ireland 4 Italy 3 Japan 1 Netherlands 5 New Zealand 1 Spain 23 Sweden 4 USA 24(1 from Nether;ands 1 from Spain 2 from Japan))
First: EPI_ISL_19276081, France, 2024-5-14 Latest: EPI_ISL_19386429,Canada, 2024-8-22
9/71 in Brazil seqs from 2024/8/1
usher